Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator

Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of auton...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2003-06, Vol.101 (12), p.4717-4724
Hauptverfasser: Ramezani, Ali, Hawley, Teresa S., Hawley, Robert G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4724
container_issue 12
container_start_page 4717
container_title Blood
container_volume 101
creator Ramezani, Ali
Hawley, Teresa S.
Hawley, Robert G.
description Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon-β scaffold attachment region (IFN-SAR) and the chicken β-globin 5′ DNase I hypersensitive site 4 (5′HS4) insulator both separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a—pooled populations as well as individual clones harboring single integrants—were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5′HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5′HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector–mediated gene transfer applications.
doi_str_mv 10.1182/blood-2002-09-2991
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73364444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120506319</els_id><sourcerecordid>73364444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-4e5438aa981e22c3fafc643ff30fb2b1e0f26c65522719191b952e3c69e83eb83</originalsourceid><addsrcrecordid>eNp9kc2OFCEUhYnROD2jL-DCsNEdyk8VXSRuzERHk0l0oWtCUZculIYRqE7mQXyReZB5JqnpTmYnLEhuvnMuOQehV4y-Y2zg78eQ0kQ4pZxQRbhS7AnasJ4PpI3oU7ShlErSqS07Q-el_KKUdYL3z9EZ4_0gJes26O93yC7lvYkWCDZxwsU4qLcE4rzOJhwgVn_w2QR8AFtTLtimWI2PPu5wnQHPS5NjH2uzgpwiub_DxRrnUpiwqdXYed9McIadT_FhySqzs7e_IeL7O7ILafSrRVmCaSteoGfOhAIvT-8F-vn504_LL-T629XXy4_XxHZcVtJB34nBGDUw4NwKZ5yVnXBOUDfykQF1XFrZ95xvmWp3VD0HYaWCQcA4iAv09uh7k9OfBUrVe18shGAipKXorRCya6eB_AjanErJ4PRN9nuTbzWjei1DP5Sh1zI0VXoto4len9yXcQ_To-SUfgPenADT8gout8R9eeS6YSsHrhr34chBy-LgIetiPazt-Nwq0VPy__vHP5KsrIs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73364444</pqid></control><display><type>article</type><title>Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ramezani, Ali ; Hawley, Teresa S. ; Hawley, Robert G.</creator><creatorcontrib>Ramezani, Ali ; Hawley, Teresa S. ; Hawley, Robert G.</creatorcontrib><description>Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon-β scaffold attachment region (IFN-SAR) and the chicken β-globin 5′ DNase I hypersensitive site 4 (5′HS4) insulator both separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a—pooled populations as well as individual clones harboring single integrants—were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5′HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5′HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector–mediated gene transfer applications.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2002-09-2991</identifier><identifier>PMID: 12586614</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Antigens, CD34 - analysis ; Applied cell therapy and gene therapy ; Binding Sites ; Biological and medical sciences ; Blotting, Southern ; Cell Differentiation ; Cell Line ; Cells, Cultured ; Chickens ; DNA - analysis ; Erythroid-Specific DNA-Binding Factors ; Fetal Blood - cytology ; Gene Expression ; Genetic Vectors - therapeutic use ; Globins - genetics ; Green Fluorescent Proteins ; Hematopoietic Stem Cells - immunology ; Hematopoietic Stem Cells - metabolism ; Humans ; Insulator Elements - genetics ; Interferon-beta - genetics ; Lentivirus - genetics ; Luminescent Proteins - genetics ; Medical sciences ; Monocytes - metabolism ; Nuclear Matrix-Associated Proteins - genetics ; Nuclear Matrix-Associated Proteins - metabolism ; Peptide Elongation Factor 1 - genetics ; Promoter Regions, Genetic ; Terminal Repeat Sequences ; Transcription Factors - genetics ; Transfection ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Blood, 2003-06, Vol.101 (12), p.4717-4724</ispartof><rights>2003 American Society of Hematology</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-4e5438aa981e22c3fafc643ff30fb2b1e0f26c65522719191b952e3c69e83eb83</citedby><cites>FETCH-LOGICAL-c426t-4e5438aa981e22c3fafc643ff30fb2b1e0f26c65522719191b952e3c69e83eb83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14876829$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12586614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramezani, Ali</creatorcontrib><creatorcontrib>Hawley, Teresa S.</creatorcontrib><creatorcontrib>Hawley, Robert G.</creatorcontrib><title>Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator</title><title>Blood</title><addtitle>Blood</addtitle><description>Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon-β scaffold attachment region (IFN-SAR) and the chicken β-globin 5′ DNase I hypersensitive site 4 (5′HS4) insulator both separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a—pooled populations as well as individual clones harboring single integrants—were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5′HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5′HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector–mediated gene transfer applications.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Antigens, CD34 - analysis</subject><subject>Applied cell therapy and gene therapy</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Blotting, Southern</subject><subject>Cell Differentiation</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Chickens</subject><subject>DNA - analysis</subject><subject>Erythroid-Specific DNA-Binding Factors</subject><subject>Fetal Blood - cytology</subject><subject>Gene Expression</subject><subject>Genetic Vectors - therapeutic use</subject><subject>Globins - genetics</subject><subject>Green Fluorescent Proteins</subject><subject>Hematopoietic Stem Cells - immunology</subject><subject>Hematopoietic Stem Cells - metabolism</subject><subject>Humans</subject><subject>Insulator Elements - genetics</subject><subject>Interferon-beta - genetics</subject><subject>Lentivirus - genetics</subject><subject>Luminescent Proteins - genetics</subject><subject>Medical sciences</subject><subject>Monocytes - metabolism</subject><subject>Nuclear Matrix-Associated Proteins - genetics</subject><subject>Nuclear Matrix-Associated Proteins - metabolism</subject><subject>Peptide Elongation Factor 1 - genetics</subject><subject>Promoter Regions, Genetic</subject><subject>Terminal Repeat Sequences</subject><subject>Transcription Factors - genetics</subject><subject>Transfection</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2OFCEUhYnROD2jL-DCsNEdyk8VXSRuzERHk0l0oWtCUZculIYRqE7mQXyReZB5JqnpTmYnLEhuvnMuOQehV4y-Y2zg78eQ0kQ4pZxQRbhS7AnasJ4PpI3oU7ShlErSqS07Q-el_KKUdYL3z9EZ4_0gJes26O93yC7lvYkWCDZxwsU4qLcE4rzOJhwgVn_w2QR8AFtTLtimWI2PPu5wnQHPS5NjH2uzgpwiub_DxRrnUpiwqdXYed9McIadT_FhySqzs7e_IeL7O7ILafSrRVmCaSteoGfOhAIvT-8F-vn504_LL-T629XXy4_XxHZcVtJB34nBGDUw4NwKZ5yVnXBOUDfykQF1XFrZ95xvmWp3VD0HYaWCQcA4iAv09uh7k9OfBUrVe18shGAipKXorRCya6eB_AjanErJ4PRN9nuTbzWjei1DP5Sh1zI0VXoto4len9yXcQ_To-SUfgPenADT8gout8R9eeS6YSsHrhr34chBy-LgIetiPazt-Nwq0VPy__vHP5KsrIs</recordid><startdate>20030615</startdate><enddate>20030615</enddate><creator>Ramezani, Ali</creator><creator>Hawley, Teresa S.</creator><creator>Hawley, Robert G.</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030615</creationdate><title>Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator</title><author>Ramezani, Ali ; Hawley, Teresa S. ; Hawley, Robert G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-4e5438aa981e22c3fafc643ff30fb2b1e0f26c65522719191b952e3c69e83eb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Antigens, CD34 - analysis</topic><topic>Applied cell therapy and gene therapy</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Blotting, Southern</topic><topic>Cell Differentiation</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Chickens</topic><topic>DNA - analysis</topic><topic>Erythroid-Specific DNA-Binding Factors</topic><topic>Fetal Blood - cytology</topic><topic>Gene Expression</topic><topic>Genetic Vectors - therapeutic use</topic><topic>Globins - genetics</topic><topic>Green Fluorescent Proteins</topic><topic>Hematopoietic Stem Cells - immunology</topic><topic>Hematopoietic Stem Cells - metabolism</topic><topic>Humans</topic><topic>Insulator Elements - genetics</topic><topic>Interferon-beta - genetics</topic><topic>Lentivirus - genetics</topic><topic>Luminescent Proteins - genetics</topic><topic>Medical sciences</topic><topic>Monocytes - metabolism</topic><topic>Nuclear Matrix-Associated Proteins - genetics</topic><topic>Nuclear Matrix-Associated Proteins - metabolism</topic><topic>Peptide Elongation Factor 1 - genetics</topic><topic>Promoter Regions, Genetic</topic><topic>Terminal Repeat Sequences</topic><topic>Transcription Factors - genetics</topic><topic>Transfection</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramezani, Ali</creatorcontrib><creatorcontrib>Hawley, Teresa S.</creatorcontrib><creatorcontrib>Hawley, Robert G.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramezani, Ali</au><au>Hawley, Teresa S.</au><au>Hawley, Robert G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2003-06-15</date><risdate>2003</risdate><volume>101</volume><issue>12</issue><spage>4717</spage><epage>4724</epage><pages>4717-4724</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon-β scaffold attachment region (IFN-SAR) and the chicken β-globin 5′ DNase I hypersensitive site 4 (5′HS4) insulator both separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a—pooled populations as well as individual clones harboring single integrants—were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5′HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5′HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector–mediated gene transfer applications.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>12586614</pmid><doi>10.1182/blood-2002-09-2991</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2003-06, Vol.101 (12), p.4717-4724
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_73364444
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Antigens, CD34 - analysis
Applied cell therapy and gene therapy
Binding Sites
Biological and medical sciences
Blotting, Southern
Cell Differentiation
Cell Line
Cells, Cultured
Chickens
DNA - analysis
Erythroid-Specific DNA-Binding Factors
Fetal Blood - cytology
Gene Expression
Genetic Vectors - therapeutic use
Globins - genetics
Green Fluorescent Proteins
Hematopoietic Stem Cells - immunology
Hematopoietic Stem Cells - metabolism
Humans
Insulator Elements - genetics
Interferon-beta - genetics
Lentivirus - genetics
Luminescent Proteins - genetics
Medical sciences
Monocytes - metabolism
Nuclear Matrix-Associated Proteins - genetics
Nuclear Matrix-Associated Proteins - metabolism
Peptide Elongation Factor 1 - genetics
Promoter Regions, Genetic
Terminal Repeat Sequences
Transcription Factors - genetics
Transfection
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
title Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T13%3A10%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Performance-%20and%20safety-enhanced%20lentiviral%20vectors%20containing%20the%20human%20interferon-%CE%B2%20scaffold%20attachment%20region%20and%20the%20chicken%20%CE%B2-globin%20insulator&rft.jtitle=Blood&rft.au=Ramezani,%20Ali&rft.date=2003-06-15&rft.volume=101&rft.issue=12&rft.spage=4717&rft.epage=4724&rft.pages=4717-4724&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2002-09-2991&rft_dat=%3Cproquest_cross%3E73364444%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73364444&rft_id=info:pmid/12586614&rft_els_id=S0006497120506319&rfr_iscdi=true